Signaling Pathways - Hepatocellular Carcinoma - Pulmonary Arterial Hypertension - Rheumatoid Arthritis - Bladder Cancer
清除全部
- A4138 Tofacitinib (CP-690550,Tasocitinib)1 Citation中文名: 托法替尼,托法替布Target: JAKSummary: Janus激酶抑制剂
- A4135 Tofacitinib (CP-690550) Citrate2 Citation中文名: 托法替尼Target: JAKSummary: JAK抑制剂
- A3014 BGJ3981 CitationTarget: FGFRSummary: FGFR抑制剂
- A3012 Ruxolitinib (INCB018424)4 Citation中文名: 鲁索替尼Target: JAKSummary: JAK抑制剂
- A8182 3-Deazaneplanocin A (DZNep) hydrochloride1 Citation中文名: 3-去氮腺嘌呤A盐酸盐Target: EZH2Summary: SAHH和EZH2抑制剂
- A8178 Panobinostat (LBH589)10 Citation中文名: 帕比司他Target: Histone Deacetylases (HDACs)Summary: HDAC抑制剂